|
1
|
Robertson L, Evans C and Fowkes FG:
Epidemiology of chronic venous disease. Phlebology. 23:103–111.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rabe E, Guex JJ, Puskas A, Scuderi A,
Fernandez Quesada F and Coordinators VC: VCP Coordinators:
Epidemiology of chronic venous disorders in geographically diverse
populations: Results from the Vein Consult Program. Int Angiol.
31:105–115. 2012.PubMed/NCBI
|
|
3
|
Jull A, Waters J and Arroll B:
Pentoxifylline for treatment of venous leg ulcers: A systematic
review. Lancet. 359:1550–1554. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jawien A, Grzela T and Ochwat A:
Prevalence of chronic venous insufficiency (CVI) in men and women
in Poland: Multicenter cross-sectional study in 40095 patients.
Phlebology. 18:110–122. 2003. View Article : Google Scholar
|
|
5
|
Zahariev T, Anastassov V, Girov K,
Goranova E, Grozdinski L, Kniajev V and Stankev M: Prevalence of
primary chronic venous disease: The Bulgarian experience. Int
Angiol. 28:303–310. 2009.PubMed/NCBI
|
|
6
|
Vlajinac HD, Radak DJ, Marinkovic JM and
Maksimovic MZ: Risk factors for chronic venous disease. Phlebology.
27:416–422. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zolotukhin IA, Seliverstov EI, Shevtsov
YN, Avakiants IP, Nikishkov AS, Tatarintsev AM and Kirienko AI:
Prevalence and risk factors for chronic venous disease in the
general Russian population. Eur J Vasc Endovasc Surg. 54:752–758.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
National Institute of Statistics.
https://www.indexmundi.com/romania/median_age.htmlMay
29–2018
|
|
9
|
Sinabulya H, Holmberg A and Blomgren L:
Interobserver variability in the assessment of the clinical
severity of superficial venous insufficiency. Phlebology. 30:61–65.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Geux JJ, Rabe E, Escotto SI, Escudero JR,
Scuderi A and Yowono HS; Vein Consult Program coordinators, : The
‘C0s’ patient: Worldwide results from the Vein Consult Program.
Phlebolymphology. 19:182–192. 2012.
|
|
11
|
Serra R, Andreucci M, De Caridi G, Massara
M, Mastroroberto P and de Franciscis S: Functional chronic venous
disease: A systematic review. Phlebology. 32:588–592. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
O'Donnell CA: Variation in GP referral
rates: What can we learn from the literature? Fam Pract.
17:462–471. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bozkurt B, Rabe E and Sharkawy M: Chronic
venous disease and Haemorrhoidal disease: Their management and
treatment MASTERCLASS (Lisbon, Portugal, 23rd-24th September 2016).
EMJ Dermatol. 5 Suppl 2:2–13. 2017.
|
|
14
|
Ramelet AA, Boisseau MR, Allegra C,
Nicolaides A, Jaeger K, Carpentier P, Cappelli R and Forconi S:
Veno-active drugs in the management of chronic venous disease. An
international consensus statement: Current medical position,
prospective views and final resolution. Clin Hemorheol Microcirc.
33:309–319. 2005.PubMed/NCBI
|
|
15
|
Nicolaides AN, Allegra C, Bergan J,
Bradbury A, Cairols M, Carpentier P, Comerota A, Delis C, Eklof B,
Fassiadis N, et al: Management of chronic venous disorders of the
lower limbs: Guidelines according to scientific evidence. Int
Angiol. 27:1–59. 2008.PubMed/NCBI
|
|
16
|
Brănișteanu DE, Nichifor M, Dorobăț CM,
Brănișteanu DC, Petrariu FD, Molodoi AD, Radu DC and Boda D: Use of
textile biomaterials for the topic treatment of chronic venous
disease. Rom Biotechnol Lett. 20:10618–10625. 2015.
|
|
17
|
Nwabudike LC and Tatu AL: Magistral
prescription with silver nitrate and Peru Balsam in difficult to
heal diabetic foot ulcers. Am J Ther. Jun 13–2017.(Epub ahead of
print). View Article : Google Scholar
|
|
18
|
Căruntu C, Negrei C, Boda D, Constantin C,
Căruntu A and Neagu M: Biotechnological advances for diagnosis of
peripheral diabetic neuropathy. Rom Biotechnol Lett. 19:9846–9858.
2014.
|
|
19
|
Ratiu MP, Purcarea I, Popa F, Purcarea VL,
Purcarea TV, Lupuleasa D and Boda D: Escaping the economic turn
down through performing employees, creative leaders and growth
driver capabilities in the Romanian pharmaceutical industry.
Farmacia. 59:119–130. 2011.
|
